Knight Therapeutics, Inc.

36
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA4990531069
CAD
6.05
0.01 (0.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Operating Income
371.00
328.00
293.00
243.00
199.00
47.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
371.00
328.00
293.00
243.00
199.00
47.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
73.00
51.00
56.00
51.00
46.00
12.00
Operating Expenses
9.00
12.00
6.00
3.00
3.00
1.00
General and Administration Expenses
99.00
83.00
88.00
72.00
65.00
20.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
363.00
321.00
310.00
254.00
220.00
48.00
Operating Profit (PBDIT) excl Other Income
7.00
6.00
-16.00
-10.00
-20.00
0.00
Other Income
15.00
-2.00
24.00
4.00
6.00
25.00
Operating Profit (PBDIT)
75.00
54.00
70.00
41.00
17.00
29.00
Interest
9.00
12.00
6.00
3.00
3.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
53.00
50.00
62.00
47.00
32.00
4.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
2.00
-21.00
-43.00
6.00
32.00
21.00
Provision for Tax
-2.00
-5.00
-14.00
-8.00
0.00
4.00
Profit After Tax
4.00
-16.00
-29.00
15.00
42.00
14.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.04
-0.16
-0.26
0.13
0.32
0.10
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 13.13% vs 11.80% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 16.99% vs 138.78% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -26.15% vs 89.21% in Dec 2023

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2024 is 125.73% vs 43.68% in Dec 2023

Compare Profit and Loss Results of Knight Therapeutics, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(CAD)
Change(%)
No of Months
12
12
Operating Income
371.00
65.00
306.00
470.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
371.00
65.00
306.00
470.77%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
73.00
0.00
73.00
0%
Operating Expenses
9.00
5.00
4.00
80.00%
General and Administration Expenses
99.00
56.00
43.00
76.79%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
363.00
61.00
302.00
495.08%
Operating Profit (PBDIT) excl Other Income
7.00
3.00
4.00
133.33%
Other Income
15.00
2.00
13.00
650.00%
Operating Profit (PBDIT)
75.00
5.00
70.00
1,400.00%
Interest
9.00
5.00
4.00
80.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
53.00
0.00
53.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2.00
0.00
2.00
0%
Provision for Tax
-2.00
0.00
-2.00
0%
Profit After Tax
4.00
0.00
4.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.0427
-0.0219
0.06
294.98%
Profit And Loss - Net Sales
Net Sales 371.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 13.13% vs 11.80% in Dec 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.52 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.99% vs 138.78% in Dec 2023

Profit And Loss - Interest
Interest 9.22 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -26.15% vs 89.21% in Dec 2023

Profit And Loss - Profit After Tax
Profit After Tax 4.33 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 125.73% vs 43.68% in Dec 2023